Increasing and planned dose intensity of doxorubicin, cyclophosphamide and etoposide (ACE) by adding recombinant human methionyl granulocyte colony-stimulating factor (G-CSF; filgrastim) in the treatment of small cell lung cancer (SCLC). Medical Research Council Lung Cancer Working Party.
Clark, P I
Smith, D B
Girling, D J
Stephens, R J
AffiliationWythenshawe Hospital, Manchester, UK.